EUVIMEDEUVIMED entdecken
Crossref

Mitochondrial gene SLC25A24 regulated anti-tumor immunity and inhibited the proliferation and metastasis of colorectal cancer by PKG1-dependent cGMP/PKG1 pathway

Yan Gao, Yinghui Peng, Yulai Zhou, Jiang Zhu, Shenao Fu, Yihong Chen, Changjing Cai, Ying Han, Hong Shen, Shan Zeng, Lei Mao, Zemin Xiao

International Immunopharmacology · 2025-06 · 157 · 114664

DOI: 10.1016/j.intimp.2025.114664 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025-06. Verfasst von Yan Gao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; National Clinical Research Center for Geriatric Di…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cyclic GMP-Dependent Protein Kinases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Cancer Research Foundation, National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a leading cause of cancer-related mortality globally, with metastasis playing a key role in its unfavorable prognosis. Emerging research has emphasized the pivotal role of mitochondria in tumor immune regulation. Nevertheless, the clinical relevance and functional role of SLC25A24, a mitochondrial solute carrier, in CRC remain largely unexplored. Through bioinformatics analyses and validation in clinical cohorts, this study identifies SLC25A24 as an independent prognostic marker in CRC, significantly linked to immune infiltration in CRC tissues. Our findings demonstrated that SLC25A24 expression is markedly reduced in CRC cell lines and tissues. Kaplan-Meier survival analysis revealed that lower SLC25A24 expression is associated with worse overall survival and progression-free survival in CRC patients. Interestingly, SLC25A24 expression was higher in microsatellite instability (MSI) CRC, which shows greater responsiveness to immune checkpoint inhibitors (ICIs). Functional experiments indicated that SLC25A24 overexpression suppresses CRC cell proliferation, migration, and invasion. Mechanistic studies revealed that SLC25A24 positively regulates the cGMP/PKG1 signaling pathway in CRC, influencing mitochondrial potential, apoptosis, and proliferation-related markers. This research highlights the SLC25A24-PKG1 axis as a potential therapeutic target to bolster anti-tumor immunity and curb CRC progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCyclic GMP-Dependent Protein KinasesHumansCell ProliferationSignal TransductionCell Line, TumorCyclic GMPCell MovementFemaleMaleGene Expression Regulation, NeoplasticMitochondriaApoptosisAnimalsPrognosisNeoplasm Metastasis

Stichwörter der Autor:innen

Colorectal cancerImmunotherapyMSISLC25A24cGMP/PKG1

Substanzen

Cyclic GMPCyclic GMP-Dependent Protein Kinases

Autor:innen und Institutionen

  • Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 4…
  • Department of Oncology, Yueyang People's Hospital, Yueyang Hospital Afliated to Hunan Normal University, Yueyang 414000, Hunan, China. Electronic address: maolei19842007@163.com.
  • Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University 818 Renmin Rd, Wuling District, Changde, Hunan 415000, China. Electronic address: xiaozemindoc@163.com.

Förderung

  • Cancer Research Foundation
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Hunan Province
  • Key Research and Development Project of Hainan Province

Zitieren

APA

Gao, Y., Peng, Y., Zhou, Y., Zhu, J., Fu, S., Chen, Y., Cai, C., Han, Y., Shen, H., Zeng, S., Mao, L., & Xiao, Z. (2025). Mitochondrial gene SLC25A24 regulated anti-tumor immunity and inhibited the proliferation and metastasis of colorectal cancer by PKG1-dependent cGMP/PKG1 pathway. International Immunopharmacology, 157, 114664. https://doi.org/10.1016/j.intimp.2025.114664

Vancouver

Gao Y, Peng Y, Zhou Y, Zhu J, Fu S, Chen Y, et al. Mitochondrial gene SLC25A24 regulated anti-tumor immunity and inhibited the proliferation and metastasis of colorectal cancer by PKG1-dependent cGMP/PKG1 pathway. International Immunopharmacology. 2025;157:114664. doi:10.1016/j.intimp.2025.114664

BibTeX
@article{Gao2025,
  author = {Gao, Yan and Peng, Yinghui and Zhou, Yulai and Zhu, Jiang and Fu, Shenao and Chen, Yihong and Cai, Changjing and Han, Ying and Shen, Hong and Zeng, Shan and Mao, Lei and Xiao, Zemin},
  title = {Mitochondrial gene SLC25A24 regulated anti-tumor immunity and inhibited the proliferation and metastasis of colorectal cancer by PKG1-dependent cGMP/PKG1 pathway},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {157},
  pages = {114664},
  doi = {10.1016/j.intimp.2025.114664}
}
Kostenlos starten →